Web Analytics


English English

Home China Business Law Journal

China Business Law Journal

Determining liable ‘illicit gains’ from fiduciary breach

By Jiang Xuan and Xin Xiangrong, Zhong Lun Law Firm

Silk Road gateway: Establishing a representative office in Uzbekistan

By Wang Jihong and Chen Haobi, Zhong Lun Law Firm

When executives move: Digital defences for trade secrets

By Ethan Zhang, Joint-Win Partners

Research, recalibrate, repeat

Market shakeups lead to increasingly complex dispute issues and novel investor strategies to resolve them

Countering RE dilemma of ‘nominated subcontractors’

By Tony Wang and Hussein Hu, Wintell
This article systematically analyses prevailing judicial trends and compliance essentials, offering practical strategies for risk isolation and contract management

Guard your secrets

Nuctech’s legal director decodes confidentiality agreements

No more wild west

Revised Anti-Unfair Competition Law steps up platforms' gatekeeping duties

Overview of Sierra Leone’s mining legislation

By Cheng Jun and Li Ji, Zhong Lun Law Firm

Australia’s FIRB: A guide for Chinese investors

By Wang Jihong and Chen Haobi, Zhong Lun Law Firm

Hong Kong proposes enhancements to regulate money lenders

By Rossana Chu and Beverly Fu, YYC Legal

No time to rest

Revenue data from 111 law firms highlights immense pressure to survive

Risk boundaries of dual controllers under Company Law

By Liu Jing and Gao Xiya, Han Kun Law Offices

Criminal liability in China on unlawful corporate rights protection

By Xu Rui and Li Rujia, Starrise Law Firm

Securing the legal framework for stable coins

By Jeffery Quan and Ray Chuen, ETR Law Firm

Compliance in clinical trials for drug development

By Wu Kun and Gao Yi, Blossom & Credit Law Firm

Final settlement based on audit: Managing construction risks

By Xu Haitao and He Xiaoyan, Anli Partners

CBLJ Forum Beijing 2025

The event attracted more than 500 GCs and senior executives, featuring 13 panel discussions and 80 speakers

Into compliance: Deeper waters

Senior partners dissect new compliance challenges while offering advice for navigating deeper waters of regulation

Embracing risk

As capital markets begin to resurrect, how can businesses capitalise on opportunities while hazards and nagging uncertainties remain?

Case analysis: Patent dispute settled with compensation

By Nancy Qu and Rose Xu, Chang Tsi & Partners

Multinational antitrust reviews in pharma M&A

By Angus Xi, Han Kun Law Offices

Walking a fine line

In-house counsel are speeding up a necessary role transition from risk controllers to strategic partners

Pharma market access and compliance in Pakistan

By Donna Tang and Syed Abdullah Anwer, TAHOTA Law Firm

Out-licensing is in

China’s pharmaceutical giants have made out-licensing drugs a major part of their business development strategy as they transition from developing generics to innovative drugs

Investor tactics for Zimbabwe mining joint ventures

By Cheng Jun and Zhao Yufeng, Zhong Lun Law Firm

Directors’ call for capital independence

By Jiang Xuan and He Lingyu, Zhong Lun Law Firm

MOST POPULAR

CBLJ IHCA Feature Image

In-house Counsel Awards 2026

Following months of market research, we have selected these outstanding in-house counsel and their teams

CORRESPONDENTS

Preparing for Hong Kong’s paperless securities regime

By Stella Yeung and Stephen Luo, Jingtian & Gongcheng

How can minority shareholders seek relief from profit hoarding?

By Jiang Xuan and Yang Yue, Zhong Lun Law Firm

Infringement risks of AIGC in entertainment industry (Part 2)

By Jiang Shen and Xu Wen, Jingtian & Gongcheng

FEATURES

China’s new environmental code

Bundled and binding

A 1,200-article code, five interlocking books, and one tighter leash on Chinese business. The clock to August 2026 is ticking

不容有瑕

No flaws allowed

While stock exchanges lower barriers to atrract emerging sector issuers, regulators focus on accountability of listco and intermediaries at the top corporate level

CBLJ IHCA Feature Image

In-house Counsel Awards 2026

Following months of market research, we have selected these outstanding in-house counsel and their teams

PRACTITIONERS' PERSPECTIVES

Preserving listing status against delisting red line

By Xu Zhiyuan, Tahota Law Firm
IPO to M&A Shift

IPO alternative: Public M&A route to capital markets

By Kang Xiaoyang, Kangda Law Firm
Red-chip restructuring in China

Unwinding red-chip structures

By Vincent Shen, Commerce & Finance Law Offices

Follow us on LinkedIn

Follow now